Literature DB >> 3263326

Interleukin-1 and tumor necrosis factor production by tumor-associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients.

J S Economou1, S D Colquhoun, T M Anderson, W W McBride, S Golub, E C Holmes, D L Morton.   

Abstract

The production of interleukin-1 (IL-1) and tumor necrosis factor (TNF) by tumor-associated mononuclear leukocytes (TAML) and peripheral mononuclear leukocytes (PMBL) from 9 otherwise untreated patients with a variety of malignancies (lung, sarcoma, stomach, renal) was assessed. Cells were cultured for 24 hr in vitro in the presence or absence of lipopolysaccharide (LPS), and IL-1 and TNF levels were measured in culture supernatants. TNF production was comparable between TAMLs and PBMLs. However, a striking defect in IL-1 production by TAMLs was noted. There was no basal production of IL-1 and LPS-stimulated TAMLs produced only 1% the amount of IL-1 produced by LPS-stimulated PBMLs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263326     DOI: 10.1002/ijc.2910420514

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Immunological suppression after surgery in scoliosis patients.

Authors:  N Suzuki; O Kaneko; T Nakayama; Y Fukuiya; S Kuge; Y Fujimura
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

2.  Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.

Authors:  A J Beniers; R J van Moorselaar; W P Peelen; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1991

3.  Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients.

Authors:  K Jhaver; A De; S Advani; J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  The monocyte tumor necrosis factor-alpha production in patients with acute leukemia in complete remission.

Authors:  M Aiso; Y Iizuka; H I Kang; S Sawada; T Ohshima; T Horie
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

5.  Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.

Authors:  Grazia Malaponte; Salvatore S Signorelli; Valentina Bevelacqua; Jerry Polesel; Martina Taborelli; Claudio Guarneri; Concettina Fenga; Kazou Umezawa; Massimo Libra
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

6.  Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.

Authors:  O Gallo; A M Gori; M Attanasio; F Martini; B Giusti; M Boddi; E Gallina; O Fini; R Abbate
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

7.  Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.

Authors:  V Holán; M Lipoldová
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

8.  Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

9.  Cancer immunotherapy: potential involvement of mediators.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.